- Home
- NEOV vs KOD Comparison
NEOV vs KOD Comparison
Compare NEOV & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- KOD
- Stock Information
- Founded
- NEOV 2018
- KOD 2009
- Country
- NEOV United States
- KOD United States
- Employees
- NEOV N/A
- KOD N/A
- Industry
- NEOV Industrial Machinery/Components
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEOV Miscellaneous
- KOD Health Care
- Exchange
- NEOV Nasdaq
- KOD Nasdaq
- Market Cap
- NEOV 185.8M
- KOD 186.3M
- IPO Year
- NEOV N/A
- KOD 2018
- Fundamental
- Price
- NEOV $4.85
- KOD $8.87
- Analyst Decision
- NEOV Strong Buy
- KOD Hold
- Analyst Count
- NEOV 1
- KOD 5
- Target Price
- NEOV $7.50
- KOD $6.80
- AVG Volume (30 Days)
- NEOV 238.4K
- KOD 464.3K
- Earning Date
- NEOV 02-07-2025
- KOD 11-14-2024
- Dividend Yield
- NEOV N/A
- KOD N/A
- EPS Growth
- NEOV N/A
- KOD N/A
- EPS
- NEOV N/A
- KOD N/A
- Revenue
- NEOV $2,471,178.00
- KOD N/A
- Revenue This Year
- NEOV $85.10
- KOD N/A
- Revenue Next Year
- NEOV $281.25
- KOD N/A
- P/E Ratio
- NEOV N/A
- KOD N/A
- Revenue Growth
- NEOV N/A
- KOD N/A
- 52 Week Low
- NEOV $0.63
- KOD $2.19
- 52 Week High
- NEOV $6.11
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- NEOV 51.52
- KOD 66.73
- Support Level
- NEOV $4.40
- KOD $8.12
- Resistance Level
- NEOV $5.36
- KOD $11.60
- Average True Range (ATR)
- NEOV 0.42
- KOD 0.87
- MACD
- NEOV -0.09
- KOD -0.01
- Stochastic Oscillator
- NEOV 43.27
- KOD 47.20
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.